Ozempic Face: Why It Happens and How to Minimise Facial Volume Loss

You catch your reflection in the bathroom mirror one morning and something looks different. Your cheekbones are sharper. The hollows under your eyes seem deeper. Your jawline is more defined, but not in the way you expected. You have lost 12 kg in four months on semaglutide, and your body looks better than it has in years. But your face looks older. You have heard the term "Ozempic face" online and now you are wondering if that is what you are seeing.

You are not imagining it. Facial volume loss during rapid weight loss is real and more common than most people realise. But it is also not as straightforward as the headlines suggest. This article covers what actually causes facial changes during GLP-1 treatment, who is most at risk, and what you can do to minimise the effect.

What is "Ozempic face"?

"Ozempic face" is not a medical diagnosis. It is a term that went viral on social media to describe the gaunt, hollowed-out appearance some people develop after significant weight loss on GLP-1 medications like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro).

The term is catchy, but it is also misleading. This type of facial volume loss is not unique to Ozempic or any specific medication. It happens with any form of rapid, significant weight loss, whether from GLP-1 treatment, bariatric surgery, severe calorie restriction, or illness. Dermatologists have been treating weight-loss-related facial ageing for decades, long before GLP-1 medications existed.

A 2024 review in Dermatological Reviews (Montecinos et al.) described the phenomenon as characterised by elastin and collagen loss, fat and muscle volume reduction, and excessive skin sagging in the face. The authors noted that the rapid pace of GLP-1-mediated weight loss, combined with the age of many patients, contributes to the visibility of these changes.

The reason the term caught on is that GLP-1 medications produce more dramatic weight loss than most previous approaches. When someone loses 14.9% of their body weight in 68 weeks (as seen in the STEP 1 trial; Wilding et al., NEJM 2021), the face does not get to choose where the fat comes from. Your body loses fat everywhere, including the face.

Why it happens

Your face holds more fat than you might think. The malar fat pad (the soft cushion over your cheekbones), the buccal fat pad (the fullness in your lower cheeks), and the subcutaneous fat layer throughout the face all contribute to a youthful, full appearance. When you lose significant weight, these fat deposits shrink.

Three factors drive the visible change.

First, your body does not lose fat uniformly. Some people lose facial fat disproportionately compared to other areas. This is partly genetic and partly related to how much facial fat you carry relative to your total body fat.

Second, rapid weight loss reduces the mechanical tension on skin, which can speed up the breakdown of collagen and elastin fibres. The skin that previously stretched over a fuller face now has less volume to support it, so it sags.

Third, and most relevant: the rate of weight loss matters enormously. A 2025 radiographic study (Sharma et al., Otolaryngology--Head and Neck Surgery) found that GLP-1 users experienced a median 9% decrease in total midface volume, with superficial fat dropping by 11%. The degree of volume loss correlated strongly with total weight lost. Lose weight fast and your skin does not have time to contract.

The medication itself does not cause facial ageing. Semaglutide does not target facial fat or damage facial skin. The mechanism is entirely about weight loss speed and magnitude. A person who lost the same amount of weight through diet alone over the same timeframe would see similar facial changes.

Who is more at risk

Not everyone who takes GLP-1 medication will notice facial changes. Several factors affect your risk.

Age matters most. Skin elasticity decreases as you get older. A 25-year-old losing 15% body weight will have much more skin bounce-back than a 50-year-old losing the same amount. Collagen production declines by roughly 1% per year from the mid-20s onward (Shuster et al., British Journal of Dermatology 1975), so there is less structural support to compensate for volume loss.

Total weight loss matters too. People who lose more than 15% of their body weight are more likely to notice facial changes. In the STEP 1 trial, participants lost an average of 14.9% body weight over 68 weeks. At the higher end of that range, facial volume loss becomes more visible.

Starting BMI plays a role. Someone starting at BMI 28 has less overall fat to lose, so the proportional impact on facial fat is greater. Patients with higher starting BMIs often have more subcutaneous fat reserves, which provides a buffer.

Exercise makes a difference. Resistance training helps preserve lean mass throughout the body, including facial muscle. Patients who lose weight purely through appetite suppression, without any physical activity, may experience more pronounced volume loss.

Your genetics and bone structure matter. If your face was already on the lean side before treatment, even modest fat loss will be more noticeable.

And sun damage compounds the problem. Chronic UV exposure degrades collagen and elastin over time. If your skin has accumulated years of sun damage, it has less capacity to adapt to volume changes.

How to minimise facial volume loss

Facial volume loss is not inevitable. There are practical steps to reduce the effect while you are on treatment.

The biggest one is gradual dose titration. Slower weight loss gives your skin more time to adjust. At Trimly, our doctors follow a careful titration protocol and adjust dosing based on your response, rather than rushing to the maximum dose. If you are losing weight faster than expected, your doctor may hold at a lower dose longer.

Protein intake matters too. Protein supports collagen synthesis and helps preserve lean mass. Aim for 1.2-1.6 grams of protein per kilogram of body weight daily while on GLP-1 treatment. A dietitian can help you hit these targets, especially when your appetite is reduced. See our guide on nutrition support for GLP-1 users.

Strength training preserves lean muscle mass during weight loss. You cannot "exercise" your facial muscles in a meaningful way, but maintaining overall muscle mass helps body composition, and patients who strength train tend to have better skin tone overall.

Stay hydrated. Dehydration makes skin look thinner and more hollow. GLP-1 medications can reduce your thirst signals along with your hunger signals, so you may need to consciously drink more water than you feel like drinking. Aim for at least 2 litres daily.

Wear sunscreen. UV damage accelerates collagen breakdown. SPF 30+ daily protects the collagen you have and supports skin recovery as your weight stabilises.

Consider topical retinoids. Tretinoin and similar retinoids stimulate collagen production and can help maintain skin thickness during weight loss. Talk to your doctor or dermatologist about whether this is appropriate for you.

Does it reverse on its own?

In many cases, yes, at least partially.

Once your weight stabilises, your skin begins to adapt to your new body composition. The process takes time, typically 6 to 12 months, but most patients see improvement as their skin gradually contracts and adjusts.

How much recovery you get depends on your age (younger skin bounces back faster), how much weight you lost in total, how long you maintain your new weight, and how well you care for your skin during the process.

Some patients find that the initial "gaunt" appearance actually mellows into a more naturally defined look as their skin catches up. The sharp hollows that appear at month four of rapid weight loss often soften by month 12 of weight stability.

For patients who find that the facial changes persist after their weight has stabilised, dermatological procedures like hyaluronic acid fillers or collagen-stimulating treatments are an option. A 2025 study (Lorenc et al., Aesthetic Surgery Journal) found that 85.7% of GLP-1 patients treated with a combination of dermal fillers and poly-L-lactic acid reported that their face looked less gaunt by month 9. However, these are cosmetic procedures, not part of weight management, and should be discussed with a dermatologist, not a weight loss doctor.

When to talk to your doctor

If you notice facial changes that concern you during GLP-1 treatment, bring it up at your next consultation. This is not something you need to ignore or feel embarrassed about. Facial changes are a known side effect of rapid weight loss, and your doctor has seen it before.

Your doctor may suggest holding your current dose rather than increasing it, reviewing your protein intake, or adjusting your treatment timeline, especially if you are close to your goal weight. If you want to explore cosmetic options, they can refer you to a dermatologist.

At Trimly, our doctors monitor your progress through regular check-ins and can adjust your treatment plan based on how your body is responding, not just the number on the scale.

Frequently asked questions

Does Ozempic cause ageing?

No. Ozempic (semaglutide) does not directly cause skin ageing. What happens is that rapid, significant weight loss, from any cause, can make facial ageing more visible by reducing the fat volume that gives your face a youthful appearance. The medication drives weight loss, and weight loss can expose age-related skin changes that were previously masked by facial fat.

Is Ozempic face permanent?

For most people, no. Facial volume loss often partially reverses over 6 to 12 months as your weight stabilises and your skin adapts. The degree of recovery varies based on your age, total weight lost, and skin quality. Gradual weight loss (through careful dose titration) reduces the severity of facial changes in the first place.

Can I avoid Ozempic face completely?

You may not be able to avoid all facial volume changes if you are losing significant weight, but you can minimise them. Slow dose titration, high protein intake, adequate hydration, sun protection, and strength training all help. Your doctor can also adjust your treatment plan if facial changes become a concern.

Should I stop GLP-1 treatment because of facial changes?

That depends on your priorities and your doctor's advice. For most patients, the health benefits of losing excess weight, including reduced risk of heart disease, diabetes, and metabolic syndrome, significantly outweigh the cosmetic concern of some facial volume loss. Talk to your doctor about your specific situation. Dose adjustment is usually a better option than stopping treatment entirely.

Key takeaways

• "Ozempic face" is not a medical condition. It is facial volume loss from rapid weight loss, not from the medication itself.
• How fast you lose weight matters more than which medication you take.
• Gradual dose titration and adequate protein intake are the two most effective ways to minimise the effect.
• Most facial changes partially reverse over 6-12 months once weight stabilises.
• If facial changes concern you, talk to your doctor about slowing down the treatment pace.

This article is for informational purposes only and does not constitute medical advice. Always consult your doctor before starting, stopping, or changing any medication. Individual results may vary. Trimly is a MOH-licensed telehealth clinic in Singapore (HCSA License R/25M0505/MDS/001/252).

Clinical trial results are based on controlled study conditions and may not reflect real-world outcomes. Weight loss results vary depending on individual factors including starting weight, adherence, diet, and exercise. The figures cited in this article come from specific trial populations and dosing regimens.